| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -9.5e-05 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 4.5e-05 | 1 |